Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
≥98% Purity
Oral and Capsule Research CompoundsSKU: CP-SB300
SLU-PP-332 + BAM15 Blend 300mcg
≥98% PuritySupplier batch spec; selected lots Janoshik-tested
€154.99Out of Stock
Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade SLU-PP-332 + BAM15 Blend. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Oral capsules in sealed bottle. For laboratory research use only. Not for human consumption.
📦
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
Currently Unavailable67 researchers waiting
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Purity HPLC
99.3% average HPLC purity, verified by independent third-party testing
Third-Party Tested
Janoshik report published when available
Fast Shipping
24h dispatch, EU-wide shipping from €4.99
Third-Party Tested
Supplier batch specification on every product; independent Janoshik report on selected lots
Last reviewed: 2026-06-05
About SLU-PP-332 + BAM15 Blend 300mcg
SLU-PP-332 + BAM15 Blend combines two mechanistically complementary metabolic research compounds in a single capsule: the ERRalpha/ERRgamma nuclear receptor agonist (SLU-PP-332) and the selective mitochondrial uncoupler (BAM15). The rationale follows straightforward biology -- SLU-PP-332 drives mitochondrial biogenesis (more mitochondria), while BAM15 increases energy expenditure per mitochondrion (more substrate burned per mitochondrion). Together they address both quantity and thermogenic activity of the mitochondrial pool.
Whether these effects are additive, synergistic, or antagonistic is the kind of question this blend is designed to help researchers answer. SLU-PP-332 increases oxidative capacity by building mitochondrial infrastructure; BAM15 then stresses each mitochondrion to work harder. There is a physiological analog in brown adipose tissue, which has both high mitochondrial density (PGC-1alpha/ERR driven) and constitutive uncoupling via UCP1. Studying whether pharmacological recapitulation of this dual mechanism in non-BAT tissues produces meaningful metabolic effects is a live research question.
The co-formulation also simplifies chronic study design. Both compounds have oral bioavailability, and combining them means a single daily oral dose can deliver both metabolic interventions simultaneously at a fixed ratio. This is useful for exploring the combination effect without the variability of separate administrations.
Research Applications
The blend is used in research on metabolic syndrome, mitochondrial biology, thermogenesis, adipose tissue physiology, and combination pharmacology. It is particularly suited for studies examining whether driving mitochondrial biogenesis and uncoupling simultaneously produces outcomes different from either intervention alone.
Specifications
| Parameter | Value |
|---|---|
| Component 1 | SLU-PP-332 (ERRalpha/ERRgamma agonist) |
| Component 2 | BAM15 (selective mitochondrial uncoupler) |
| Purity | ≥98% (supplier batch spec; 99.3% avg across independently tested lots, each component) |
| Format | Oral capsule blend |
| Capsules per Bottle | 100 |
| Storage | Room temperature, protect from moisture and light |
Storage
Store at room temperature in a cool, dry place. Protect from moisture and light. Both components are stable small molecules at ambient temperature.
Why combine a biogenesis driver with an uncoupler?
SLU-PP-332 increases mitochondrial number by activating ERR nuclear receptors that drive mitochondrial biogenesis. BAM15 increases energy expenditure per mitochondrion by dissipating the proton gradient. Brown adipose tissue does both naturally -- high mitochondrial density plus constitutive uncoupling via UCP1. The combination targets both levers simultaneously, addressing quantity and thermogenic activity of the mitochondrial pool. Whether pharmacologically mimicking this BAT phenotype in metabolically relevant tissues produces additive or synergistic metabolic outcomes is the research question the blend is designed to explore.
Could SLU-PP-332 and BAM15 interfere with each other?
This is an open question and part of what research with this blend can address. SLU-PP-332 works at the nuclear receptor level (hours to days timescale for gene expression changes), while BAM15 acts acutely at the mitochondrial membrane (minutes timescale). These different modes of action suggest limited direct pharmacological interference, but the cellular response to sustained uncoupling might influence the transcriptional programs that ERR activation is trying to drive. Understanding this interaction is one of the scientifically interesting aspects of using the combination.
Is this blend available as a separate powder for injection studies?
This blend is available as an oral capsule only. For injection-based research protocols, or for researchers who need independent dose control of each component, SLU-PP-332 and BAM15 are also available as separate products. The capsule blend is designed specifically for oral chronic dosing protocols where the fixed-ratio combination is appropriate.
SLU-PP-332 + BAM15 Blend is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Specification Summary
Purity99.3% avg
FormLyophilized Powder
Storage-20\u00B0C
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
Frequently Asked
Research Library
Related Research Articles
Based on category & popularity
Researchers Also Studied
500mcgSAME FIELDOral and Capsule Research Compounds
KPV Oral Capsules 500mcg
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied for its immunomodulatory signaling in gastrointestinal and immune biology research models. Alpha-MSH-derived immunomodulatory tripeptide Intestinal epithelial barrier and PepT1 transporter research NF-kB pathway modulation studies For research purposes only. Not for human consumption.
€309.99
500mcgSAME FIELDOral and Capsule Research Compounds
Oral TB-500 500mcg
Research-grade Oral TB-500. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Oral capsules in sealed bottle. For laboratory research use only. Not for human consumption.
€361.49
1000mcgSAME FIELDOral and Capsule Research Compounds
Oral BPC-157 + TB-500 Blend 1000mcg
Research-grade Oral BPC-157 + TB-500 Blend. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Oral capsules in sealed bottle. For laboratory research use only. Not for human consumption.
€722.49
500mcgSAME FIELDOral and Capsule Research Compounds
Oral BPC-157 Capsules 500mcg (60 capsules)
Enteric-coated oral BPC-157 capsules. 60 capsules per bottle, 500mcg BPC-157 per capsule (30g total per bottle). ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Supplied for in vitro research into oral peptide bioavailability and intestinal tissue protection. EU-wide 3–7 day shipping.
€137.99
